BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

2350

543264

NURECA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NURECA LIMITED performance

Today’s low

Today’s high

₹ 261.20 ₹ 290.91
₹ 289.22

52 week low

52 week high

₹ 203.62 ₹ 447.50
₹ 289.22

Open Price

₹ 269.99

Prev. Close

₹ 242.43

Volume (Shares)

844529.00

Total traded value

₹ 2442.54

Upper Circuit

₹ 290.91

Lower Circuit

₹ 193.94

info

NURECA LIMITED Share Price Update

As of the latest trading session, NURECA LIMITED share price is currently at ₹ 289.22, which is up by ₹ 46.79 from its previous closing. Today, the stock has fluctuated between ₹ 261.20 and ₹ 290.91. Over the past year, NURECA LIMITED has achieved a return of -1.32 %. In the last month alone, the return has been 14.68 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NURECA LIMITED fundamentals


  • Market cap (Cr)

    289.20

  • P/E Ratio (TTM)

    116.52

  • Beta

    0.78

  • Book Value / share

    196.16

  • Return on equity

    -0.35%

  • EPS (TTM)

    2.47

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    3.14

info icon alternate text
  • Market cap (Cr)

    287.80

  • P/E Ratio (TTM)

    116.52

  • Beta

    0.67

  • Book Value / share

    196.16

  • Return on equity

    -0.35%

  • EPS (TTM)

    2.47

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    3.14

info icon alternate text

NURECA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 37.84
Operating Expense 36.12
Net Profit 3.14
Net Profit Margin (%) 8.29
Earnings Per Share (EPS) 3.14
EBITDA 5.00
Effective Tax Rate (%) 23.60
Particulars JUN 2025 (Values in Cr)
Revenue 34.32
Operating Expense 36.08
Net Profit 0.55
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 0.55
EBITDA 1.51
Effective Tax Rate (%) 33.73
Particulars MAR 2025 (Values in Cr)
Revenue 31.75
Operating Expense 32.25
Net Profit 2.07
Net Profit Margin (%) 6.51
Earnings Per Share (EPS) 2.07
EBITDA 2.57
Effective Tax Rate (%) -37.99
Particulars DEC 2024 (Values in Cr)
Revenue 27.21
Operating Expense 32.57
Net Profit -3.29
Net Profit Margin (%) -12.09
Earnings Per Share (EPS) -3.29
EBITDA -3.21
Effective Tax Rate (%) 14.54
Particulars SEP 2024 (Values in Cr)
Revenue 32.37
Operating Expense 35.85
Net Profit -0.65
Net Profit Margin (%) -2.00
Earnings Per Share (EPS) -0.65
EBITDA 0.54
Effective Tax Rate (%) -140.74
Particulars MAR 2025 (Values in Cr)
Revenue 114.64
Operating Expense 127.65
Net Profit -0.67
Net Profit Margin (%) -0.58
Earnings Per Share (EPS) -0.67
EBITDA 2.81
Effective Tax Rate (%) -45.65
Particulars MAR 2024 (Values in Cr)
Revenue 94.52
Operating Expense 108.35
Net Profit -2.44
Net Profit Margin (%) -2.58
Earnings Per Share (EPS) -2.44
EBITDA -0.56
Effective Tax Rate (%) 25.38
Particulars MAR 2023 (Values in Cr)
Revenue 111.90
Operating Expense 130.02
Net Profit -8.42
Net Profit Margin (%) -7.52
Earnings Per Share (EPS) -8.40
EBITDA -8.23
Effective Tax Rate (%) 23.17
Particulars MAR 2022 (Values in Cr)
Revenue 255.55
Operating Expense 201.94
Net Profit 45.31
Net Profit Margin (%) 17.73
Earnings Per Share (EPS) 45.31
EBITDA 63.48
Effective Tax Rate (%) 26.12
Particulars MAR 2021 (Values in Cr)
Revenue 213.33
Operating Expense 153.66
Net Profit 46.53
Net Profit Margin (%) 21.81
Earnings Per Share (EPS) 62.25
EBITDA 64.50
Effective Tax Rate (%) 25.54
Particulars MAR 2025 (Values in Cr)
Book Value / Share 194.29
ROE % -1.12
ROCE % -0.89
Total Debt to Total Equity 0.02
EBITDA Margin 0.51
Particulars MAR 2024 (Values in Cr)
Book Value / Share 193.11
ROE % -3.14
ROCE % -4.00
Total Debt to Total Equity 0.02
EBITDA Margin -6.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 194.88
ROE % -5.37
ROCE % -6.26
Total Debt to Total Equity 0.02
EBITDA Margin -9.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 203.20
ROE % 24.55
ROCE % 32.88
Total Debt to Total Equity 0.02
EBITDA Margin 24.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.10
ROE % 52.09
ROCE % 66.51
Total Debt to Total Equity 0.08
EBITDA Margin 30.15
Particulars MAR 2025 (Values in Cr)
Book Value / Share 192.48
ROE % -0.35
ROCE % 0.34
Total Debt to Total Equity 0.02
EBITDA Margin 2.45
Particulars MAR 2024 (Values in Cr)
Book Value / Share 192.86
ROE % -1.26
ROCE % -1.42
Total Debt to Total Equity 0.01
EBITDA Margin -0.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 195.26
ROE % -4.22
ROCE % -5.16
Total Debt to Total Equity 0.02
EBITDA Margin -7.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 203.74
ROE % 24.69
ROCE % 33.01
Total Debt to Total Equity 0.02
EBITDA Margin 24.84
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.29
ROE % 52.20
ROCE % 66.65
Total Debt to Total Equity 0.08
EBITDA Margin 30.23
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 46.25
Total Assets 209.97
Total Liabilities 209.97
Total Equity 194.28
Share Outstanding 10000175
Price to Book Ratio 1.09
Return on Assets (%) 0.40
Return on Capital (%) 0.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 45.30
Total Assets 205.16
Total Liabilities 205.16
Total Equity 193.11
Share Outstanding 10000175
Price to Book Ratio 1.32
Return on Assets (%) -0.87
Return on Capital (%) -0.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.96
Total Assets 206.58
Total Liabilities 206.58
Total Equity 194.88
Share Outstanding 10000175
Price to Book Ratio 1.54
Return on Assets (%) -3.99
Return on Capital (%) -4.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 84.35
Total Assets 219.13
Total Liabilities 219.13
Total Equity 203.19
Share Outstanding 10000175
Price to Book Ratio 6.69
Return on Assets (%) 20.51
Return on Capital (%) 22.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 126.69
Total Assets 185.75
Total Liabilities 185.75
Total Equity 163.09
Share Outstanding 10000175
Price to Book Ratio 3.69
Return on Assets (%) 24.96
Return on Capital (%) 28.26
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 46.20
Total Assets 206.15
Total Liabilities 206.15
Total Equity 192.47
Share Outstanding 10000175
Price to Book Ratio 1.09
Return on Assets (%) -0.32
Return on Capital (%) -0.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 45.20
Total Assets 204.33
Total Liabilities 204.33
Total Equity 192.85
Share Outstanding 10000175
Price to Book Ratio 1.32
Return on Assets (%) -1.19
Return on Capital (%) -1.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.86
Total Assets 206.68
Total Liabilities 206.68
Total Equity 195.26
Share Outstanding 10000175
Price to Book Ratio 1.54
Return on Assets (%) -4.07
Return on Capital (%) -4.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 84.18
Total Assets 219.53
Total Liabilities 219.53
Total Equity 203.74
Share Outstanding 10000175
Price to Book Ratio 6.69
Return on Assets (%) 20.63
Return on Capital (%) 22.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 126.44
Total Assets 185.88
Total Liabilities 185.88
Total Equity 163.29
Share Outstanding 10000175
Price to Book Ratio 3.69
Return on Assets (%) 25.03
Return on Capital (%) 28.34
Particulars MAR 2025 (Values in Cr)
Net Income 1.34
Cash from Operations -17.70
Cash from Investing 8.43
Cash from Financing -0.16
Net change in Cash -10.81
Free Cash Flow -15.39
Particulars MAR 2024 (Values in Cr)
Net Income -2.54
Cash from Operations -3.96
Cash from Investing 17.57
Cash from Financing -1.30
Net change in Cash 13.56
Free Cash Flow -2.87
Particulars MAR 2023 (Values in Cr)
Net Income -10.74
Cash from Operations 14.37
Cash from Investing -16.45
Cash from Financing -1.50
Net change in Cash -7.73
Free Cash Flow 14.77
Particulars MAR 2022 (Values in Cr)
Net Income 60.98
Cash from Operations 19.35
Cash from Investing -3.08
Cash from Financing -7.30
Net change in Cash -8.99
Free Cash Flow 22.75
Particulars MAR 2021 (Values in Cr)
Net Income 62.33
Cash from Operations 49.93
Cash from Investing -110.04
Cash from Financing 92.34
Net change in Cash 17.16
Free Cash Flow 50.35
Particulars MAR 2025 (Values in Cr)
Net Income -0.46
Cash from Operations -17.51
Cash from Investing 8.56
Cash from Financing -0.78
Net change in Cash -10.77
Free Cash Flow -15.53
Particulars MAR 2024 (Values in Cr)
Net Income -3.26
Cash from Operations -4.48
Cash from Investing 17.83
Cash from Financing -1.27
Net change in Cash 13.56
Free Cash Flow -3.98
Particulars MAR 2023 (Values in Cr)
Net Income -10.95
Cash from Operations 16.18
Cash from Investing -18.30
Cash from Financing -1.50
Net change in Cash -7.75
Free Cash Flow 16.42
Particulars MAR 2022 (Values in Cr)
Net Income 61.33
Cash from Operations 19.78
Cash from Investing -3.36
Cash from Financing -7.30
Net change in Cash -8.84
Free Cash Flow 23.04
Particulars MAR 2021 (Values in Cr)
Net Income 62.49
Cash from Operations 50.16
Cash from Investing -110.48
Cash from Financing 92.33
Net change in Cash 16.96
Free Cash Flow 50.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
MSTC LIMITED 535.95 17.36 5.10 3773.09 410.80 / 809.55
INFO EDGE (I) LTD 1328.45 84.99 2.46 86139.43 1151.45 / 1838.99
INTRASOFT TECH. LTD 98.40 12.27 0.70 160.51 89.95 / 174.80
NAZARA TECHNOLOGIES LTD 264.45 79.18 2.91 9796.95 208.83 / 362.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
MSTC LIMITED 535.95 17.73 5.01 3773.09 410.80 / 809.55
Mitshi India Limited 15.70 392.50 5.07 13.82 13.01 / 19.48
AVI PRODUCTS INDIA LIMITED 31.50 0.00 1.46 10.42 18.05 / 34.58
OLYMPIA INDUSTRIES LTD. 34.98 15.01 0.48 21.07 30.70 / 55.00

NURECA LIMITED shareholding pattern

Holding

Others
35.56%
Promoter Holdings
64.32%
FII
0.07%
DII
0.03%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Saurabh Goyal 3188658.0 (31.89%) Shareholding of Promoter and Promoter Group
Payal Goyal 2459928.0 (24.6%) Shareholding of Promoter and Promoter Group
Aryan Goyal 723353.0 (7.23%) Shareholding of Promoter and Promoter Group
Nisarg Vakharia 185000.0 (1.85%) Public Shareholding
Viral Amal Parikh 108000.0 (1.08%) Public Shareholding
Nectar Biopharma Private Limited 60842.0 (0.61%) Shareholding of Promoter and Promoter Group
Smita Goyal 7.0 (0.0%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

NURECA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
289.22 19.30 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 254.60
  • 26 Days 242.50
  • 10 Days 246.00
  • 50 Days 244.70
  • 12 Days 244.50
  • 100 Days 250.10
  • 20 Days 242.50
  • 200 Days 260.90
242.31 PIVOT

First Support

235.12

First Resistance

249.62

Second Support

227.81

Second Resistance

256.81

Third Support

220.62

Third Resistance

264.12

RSI

77.93

ADX

15.06

MACD

2.07

Williams % R

-2.60

Commodity Channel Index (CCI)

419.59

Date

2025-10-17

Week

40893.00

Same Day

203239.00

Month

16066.00

1 Year

0.78

3 Year

0.73

Over 1 Month

14.68%

down

Over 1 Year

-1.32%

down

Over 3 Months

12.31%

down

Over 3 Years

-29.66%

down

Over 6 Months

16.54%

down

Over 5 Years

-14.84%

down

NURECA LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

NURECA LIMITED Share Price

Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited.

Nureca is a digitally native, consumer healthcare company with a leading presence in categories such as home diagnostics, wellness devices, and personal fitness equipment under brands like Dr Trust and Dr Physio. The Company's differentiated strategy is built around four pillars: Product Innovation, Omnichannel Distribution, Direct-to-Consumer (D2C) Excellence and In-House Manufacturing Capabilities.

The Company is engaged in the business of home healthcare and wellness products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives.

In 2017, the Company commenced business operations and launched 'Dr. Trust' brand through digital healthcare channel.

In 2018, the Company widened product basket with launching of brands in electric massages and mother & child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh.

In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Company's key products secured a warehouse drug license.

In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores.

The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited and the Company and their respective shareholders and creditors and the Scheme became effective on 23 May 2020. Pursuant to Scheme of Demerger, certain portion of business activities of Nectar Biopharma Private Limited was transferred by Nectar Biopharma Private Limited from 01 April, 2019.

Nureca Technologies Private Limited have received industrial policy approval to establish a health and wellness equipment manufacturing plant at Village Sundra, SAS Nagar, Punjab in FY 25.

Parent organization Indian Private
NSE symbol NURECA
Founded 2016
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nureca Ltd?

Answer Field

Nureca Ltd share price is for NSE ₹ 289.22 & for BSE ₹ 288.95 as on Oct 17 2025 03:30 PM.

What is the Market Cap of Nureca Ltd Share?

Answer Field

The market cap of Nureca Ltd for NSE ₹ 289.22 & for BSE ₹ 288.95 as on Oct 17 2025 03:30 PM.

What is the 52 Week High and Low of Nureca Ltd?

Answer Field

The 52 Week High and Low of Nureca Ltd for NSE is ₹ 447.50 and ₹ 203.62 and for BSE is ₹ 447.00 and ₹ 198.00.

What is 1 year return for Nureca Ltd?

Answer Field

The 1 year returns on the stock has been -1.32%.

What is the P/E Ratio of Nureca Ltd Share?

Answer Field

As on Oct 17 2025 03:30 PM the price-to-earnings (PE) ratio for Nureca Ltd share is 116.52.

What is the PB ratio of Nureca Ltd Share?

Answer Field

As on Oct 17 2025 03:30 PM, the price-to-book (PB) ratio for Nureca Ltd share is 196.16.

How to Buy Nureca Ltd Share?

Answer Field

You can trade in Nureca Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nureca Ltd Share on Bajaj Broking App?

Answer Field

To buy Nureca Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nureca Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59